Copyright
©The Author(s) 2024.
World J Stem Cells. Apr 26, 2024; 16(4): 444-458
Published online Apr 26, 2024. doi: 10.4252/wjsc.v16.i4.444
Published online Apr 26, 2024. doi: 10.4252/wjsc.v16.i4.444
Figure 1 Gossypol acetic acid decreased leucine-rich pentatricopeptide repeat-containing protein and inhibited leukemia stem cell progression.
A: Molecular structure of gossypol acetic acid (GAA) was presented; B: After being treated with 2.5, 5, 7.5, 10 μmol/L GAA for 24 h, leucine-rich pentatricopeptide repeat-containing protein was measured by performing western blot; C: After being cultured with 2.5, 5, 7.5, 10 μmol/L GAA for 24 h, cell viability was measured by performing CCK-8 assay. aP < 0.05, vs KG1a-SCs; bP < 0.01, vs KG1a-SCs; cP < 0.05, vs Kasumi-1-SCs; dP < 0.01, vs Kasumi-1-SCs; D: With presence of 2.5, 5, 7.5, 10 μmol/L GAA, colony formation assay was performed. LRPPRC: Leucine-rich pentatricopeptide repeat-containing protein; GAA: Gossypol acetic acid.
- Citation: Ai CJ, Chen LJ, Guo LX, Wang YP, Zhao ZY. Gossypol acetic acid regulates leukemia stem cells by degrading LRPPRC via inhibiting IL-6/JAK1/STAT3 signaling or resulting mitochondrial dysfunction. World J Stem Cells 2024; 16(4): 444-458
- URL: https://www.wjgnet.com/1948-0210/full/v16/i4/444.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v16.i4.444